FDA Inspection 1084698 — Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center
The FDA completed an inspection of Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center on March 8, 2019 in Westerly, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 8, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Westerly, RI (United States)